GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » YoY EPS Growth

Nextbiomedical Co (XKRX:389650) YoY EPS Growth : 88.49% (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Nextbiomedical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was 88.49%.

Nextbiomedical Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₩-52.02.

Nextbiomedical Co YoY EPS Growth Historical Data

The historical data trend for Nextbiomedical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextbiomedical Co YoY EPS Growth Chart

Nextbiomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
- 39.85 73.17 -29.79 78.13

Nextbiomedical Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -125.32 101.32 88.49

Nextbiomedical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Nextbiomedical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-262--1198)/ | -1198 |
=78.13 %

Nextbiomedical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-52.019--452)/ | -452 |
=88.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextbiomedical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Nextbiomedical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextbiomedical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » YoY EPS Growth
Comparable Companies
XKRX:397030 XKRX:475960 XKRX:228760 XKRX:334970 XKRX:078160 XKRX:011000 XKRX:140610 XKRX:064550 XKRX:372320 XKRX:086820 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Website
https://www.nextbiomedical.co.kr/kr
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Nextbiomedical Co Headlines

No Headlines